-
Psychedelic Biotech Gets U.K. Study Approval In Treatment Of Depression
Monday, August 15, 2022 - 5:05pm | 436Short-acting psychedelics company Small Pharma Inc. (OTCQB: DMTTF) has received the approval from the U.K. Medicines and Healthcare products Regulatory Authority (MHRA) and the Regional Ethics Committee for a drug interaction clinical trial to take place on national grounds. The novel study will...